Sorghum halepense (L.) Pers rhizomes inhibitory potential against diabetes and free radicals

Clinical Phytoscience

International Journal of Phytomedicine and Phytotherapy

Table 6 Consequences of rhizomes of Sorghum halepense (L.) Pers extract on the concentration of serum’s LDL cholesterol, triglycerides, VLDL cholesterol, total cholesterol and HDL cholesterol

Groups	TG (mg/dL)	Cholesterol (mg/dL)	LDL (mg/dL)	VLDL (mg/dL)	HDL (mg/dL)
Normal control	96.0 ± 1.9	88 ± 1.9	27.0 ± 2.1	19.0 ± 0.38	45.0 ± 5.8
Diabetic control	175.0 ± 1.1	97 ± 3.2	49.0 ± 1.9	35.0 ± 2.3	28.0 ± 1.7
Glibenclamide (10 mg)	112.0 ± 4.2 ^a	93 ± 2.9 ^a	32.0 ± 2.6 ^a	22.0 ± 0.84 ^a	36.0 ± 2.4 ^a
Extract (150 mg)	111.0 ± 7.02 ^a	96 ± 4.0 ^a	33.0 ± 4.6 ^a	22.12 ± 1.40 ^a	39.2 ± 2.77 ^a
Extract (300 mg)	105.0 ± 6.73 ^a	93 ± 6.2 ^a	29.0 ± 3.2 ^a	21.08 ± 1.35 ^a	43.4 ± 4.5 ^a

Represented the data (n = 5) as Mean ± SD, a shows significance at P < 0.001 (Dunnett’s-test), the normal group was compared with the untreated group and in turn, its comparison was made with extract treated group and standard, LDL Low density lipoprotein, TG Triglycerides, VLDL Very low density lipoprotein, HDL High density lipoprotein